Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|March 1, 1995
Pulmonary infiltrates in patients with haematologic malignancies: clinical usefulness of non-invasive bronchoscopic proceduresM von Eiff, M Zühlsdorf, N Roos, et al.
Blut|April 1, 1990
Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignanciesM von Eiff, M Essink, N Roos, et al.
Cancer Treatment Reviews|September 1, 1990
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparisonW Hiddemann, E Schleyer, C Uhrmeister, et al.
Behring Institute Mitteilungen|August 1, 1988
Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early deathT Büchner, W Hiddemann, M Zühlsdorf, et al.
Cancer|January 15, 1987
Tumor heterogeneity in osteosarcoma as identified by flow cytometryW Hiddemann, A Roessner, B Wörmann, et al.
Klinische Padiatrie|May 1, 1985
[DNA aneuploidy in children with acute leukemia: I. Incidence and clinical significance within the scope of the BFM studies]W Hiddemann, J Ritter, B Wörmann, et al.
Blood|August 1, 1976
DNA histogram analysis of human hemopoietic cellsB Barlogie, G Spitzer, J S Hart, et al.
Leukemia|February 16, 2000
Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalitiesW Kern, C Schoch, T Haferlach, et al.
Genes, Chromosomes & Cancer|July 31, 2001
Amplification of ribosomal RNA genes in acute myeloid leukemiaC Fonatsch, H Nowotny, E Pittermann-Höcker, et al.
Annals of Hematology|July 28, 2001
Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemiasW Kern, E Schleyer, J Braess, et al.
Pageof 18